Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis.

Gender-based reciprocal expression of transforming growth factor-beta1 and the inducible nitric oxide synthase in a rat model of cyclophosphamide-induced cystitis.
复制标题

DOI:
10.1186/1476-9255-6-23
复制
发表时间:
2009-08-19
期刊:
Journal of inflammation (London, England)
影响因子:
--
通讯作者:
Vodovotz Y
Vodovotz Y
中科院分区:
其他
文献类型:
--
作者:
Tyagi P;Tyagi V;Yoshimura N;Witteemer E;Barclay D;Loughran PA;Zamora R;Vodovotz Y

文献摘要

参考文献

相似文献

多能性细胞因子转化生长因子-β1(TGF-β1)是诱导型一氧化氮合酶(iNOS)的中心调节因子,iNOS负责炎症环境中一氧化氮(NO)的产生。以前的研究表明,NO可能来源于诱导型一氧化氮合酶(iNOS),在环磷酰胺(CYP 1A 1)诱导的膀胱炎中发挥作用。TGF-β1以潜伏形式产生,需要与潜伏相关肽(LTP)解离,以在上尿路组织损伤后作为主要抗炎和促愈合调节剂。由于TGF-β1在下尿路炎症中的作用目前尚不清楚,并且由于间质性膀胱炎(IC)的发生存在性别差异,因此本研究在雄性和雌性大鼠中检查了TGF-β1和iNOS/NO在CYP诱导的膀胱炎发病机制中的关系。Sprague-Dawley大鼠(4月龄,雌雄各半)经腹腔内连续给予150 mg/kg。尿和膀胱组织TGF-β1和NO反应产物(NO2-/NO3-)定量为膀胱灌注后时间的函数。采用免疫组化法检测膀胱组织中活性和潜伏性TGF-β1及iNOS的表达。与雄性大鼠相比,雌性大鼠甚至在基线时尿液中的NO2-/NO3-水平显著更高(p < 0.001),而在注射顺铂之前,活性或潜伏性TGF-β1的尿液水平没有基于性别的显著差异。在两种性别的膀胱中,炎症和细胞毒性变化均由前列腺素诱导,伴有NO2-/NO3-和TGF-β1尿液水平的差异。与雌性大鼠相比,雄性大鼠在暴露后的所有时间点尿中NO2-/NO3-水平均显著降低(p < 0.05),TGF-β1水平显著升高(p < 0.05)。尿NO 2-/NO 3-水平与潜伏性和活性TGF-β1呈负相关(Pearson系数女性分别为-0.72和-0.69,男性分别为-0.89和-0.76; p < 0.01)。前列腺切除术后,雄性大鼠膀胱组织中潜伏和活性TGF-β1水平均显著高于雌性大鼠(p < 0.01)。TGF-β1和iNOS蛋白主要定位于尿路上皮。本研究结果提示,CYP炎性膀胱组织中TGF-β1的表达与iNOS/NO2-/NO3-呈负相关。动物的性别似乎放大了这种炎症环境中TGF-β1和NO2-/NO3-尿液水平的差异。这些结果支持了TGF-β1可抑制与膀胱炎症相关的iNOS表达和降低全身NO2-/NO3-水平的假设,并进一步表明TGF-β1的这一特性可用于间质性膀胱炎的治疗和诊断。
The pluripotent cytokine transforming growth factor-β1 (TGF-β1) is the central regulator of inducible Nitric Oxide Synthase (iNOS) that is responsible for nitric oxide (NO) production in inflammatory settings. Previous studies have implicated a role for NO, presumably derived from iNOS, in cyclophosphamide (CYP)-induced cystitis in the bladder. TGF-β1 is produced in latent form and requires dissociation from the latency-associated peptide (LAP) to act as primary anti-inflammatory and pro-healing modulator following tissue injury in the upper urinary tract. Since the role of TGF-β1 in lower urinary tract inflammation is currently unknown, and since gender-based differences exist in the setting of interstitial cystitis (IC), the present study examined the relationship between TGF-β1 and iNOS/NO in the pathogenesis of CYP-induced cystitis in both male and female rats. Sprague-Dawley rats, 4 months of age, of either gender were given 150 mg/kg CYP intraperitoneally. Urinary and bladder tissue TGF-β1 and NO reaction products (NO2-/NO3-) were quantified as a function of time following CYP. Expression of active and latent TGF-β1 as well as iNOS in harvested bladder tissue was assessed by immunohistochemistry. Female rats had significantly higher levels of NO2-/NO3- in urine even at baseline as compared to male rats (p < 0.001), whereas there was no gender based significant difference in urine levels of active or latent TGF-β1 prior to CYP injection. Inflammatory and cytotoxic changes were induced by CYP in the bladder of both sexes that were accompanied by differences in the urine levels of NO2-/NO3- and TGF-β1. Male rats responded to CYP with significantly lower levels of NO2-/NO3- and significantly higher levels of TGF-β1 in urine (p < 0.05) as compared to females at all time points after CYP. The urine levels of NO2-/NO3- after CYP were inversely correlated to latent and active TGF-β1 (Pearson coefficient of -0.72 and -0.69 in females and -0.89 and -0.76 in males, respectively; p < 0.01). Bladder tissue of male rats exhibited significantly higher levels of both latent and active TGF-β1 (p < 0.01) compared to female rats after CYP. TGF-β1 and iNOS protein was mostly localized in the urothelium. The results of this study suggest that there exists an inverse relationship between the expression of TGF-β1 and iNOS/NO2-/NO3- in CYP-inflamed bladder. The gender of the animal appears to magnify the differences in urine levels of TGF-β1 and NO2-/NO3- in this inflammatory setting. These results support the hypothesis that TGF-β1 can suppress iNOS expression associated with bladder inflammation and reduce systemic levels of NO2-/NO3-, and further suggest that this feature of TGF-β1 can be harnessed for therapy and diagnosis of interstitial cystitis.
DOI: 10.1016/j.prostaglandins.2007.11.004
发表时间: 2008-03-01
影响因子: 2.9
作者:
Hamby, Mary E.;Hewett, James A.;Hewett, Sandra J.
通讯作者: Hewett, Sandra J.
DOI: 10.1016/0006-2952(79)90222-3
发表时间: 1979-01-01
影响因子: 5.8
作者:
COX, PJ
通讯作者: COX, PJ
DOI: 10.1016/j.transproceed.2006.02.070
发表时间: 2006-06-01
影响因子: 0.9
作者:
Kim, C. -D.;Cho, Y. -J.;Kim, Y. L.
通讯作者: Kim, Y. L.
DOI: 10.1016/s0002-9440(10)65444-2
发表时间: 1999-06-01
影响因子: 6
作者:
Lagadec, P;Raynal, S;Jeannin, JF
通讯作者: Jeannin, JF
DOI: 10.1016/s0891-5849(96)00493-5
发表时间: 1997-01-01
影响因子: 7.4
作者:
Islam, KN;Kayanoki, Y;Taniguchi, N
通讯作者: Taniguchi, N